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Background: Hepatitis C virus (HCV) infection in Egypt has reached an epidemic proportion and is associated with many extra hepatic
manifestations; Glomerulonephritis (GN) is one of the most consequences of HCV infection often resulting in end stage renal disease in some
cases. Detection of viral genome or particles within the kidney biopsies from HCV-infected patients has proven to be difficult. Histological
characterization of renal lesions still represents a major challenge. The aim of our work was to describe the histological pattern of HCV-
associated nephropathy.
Methods: Fifty Patients out of 233 presented to Mansoura Urology and Nephrology clinic with manifestations of glomerular disease
were screened for HCV antibodies by a 3rd generation ELISA test. Those tested positive for HCV antibodies were confirmed by PCR for
HCV-RNA and subjected to more detailed clinical, biochemical and histological study. Kidney biopsies and in appropriate cases liver
biopsies were examined by LM and electron microscopy (EM).
Results: Histological study of renal biopsies revealed membranoproliferative (MPGN) type 1 to be the most common lesion encountered
(54%), followed by focal segmental glomerulosclerosis (FSGS) (24%), mesangioproliferative GN (18%), membranous nephropathy (MN)
(4%) in that order. EM examinations of renal biopsies were successful in identifying HCV like particles in frozen renal tissue.
Conclusion: HCV-associated glomerulopathy is a distinct category of glomerulonephritis. Results of LM showed some peculiar features.
In addition, we were successful in location and detection of HCV particles in renal tissues by EM.
D 2005 Elsevier Inc. All rights reserved.
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In Egypt, HCV infection has reached epidemic propor-
tions with up to 21.9% of the population affected. This has
been partly attributed to the routine parenteral administration
of anti-Shistosomal drugs during the 1960s (Frank et al.,
2000). The incidence of HCV infection in Egypt is being
studied both at a community level as well as by the
Hepatology committee of the Ministry of Health. In the
general population, anti-HCV has been reported in 12% of0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.01.013
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E-mail address: asabry20@yahoo.com (A. Sabry).children in a rural primary school, in 18% of the general
population in a rural area (increasing with age) and in 16% of
children with endemic hepatomegaly. In multitransfused
children and patients on maintenance hemodialysis, the
frequency has been found to be 44.5% and 46.0%,
respectively (Zakaria et al., 1994).
Extra-hepatic manifestations of HCV infection are diverse
and appear during late middle age (Wilson, 1997). Among
these, glomerulonephritis, arthritis, dermal vasculitis and
sialadenitis are thought to develop as a result of the deposition
of immune complexes. Membranoproliferative glomerulo-
nephritis (MPGN) is thought to be the most common whether
cryoglobulinemic or non-cryoglobulinemic (Johnson et al.,005) 10–16
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infection and FSGS (Altraif et al., 1995), membranous
nephropathy (Stehman-Breen et al., 1995) has also been
reported. Other forms of renal disease have been previously
linked to chronic HCV infection including acute exudative
and proliferative glomerulonephritis and IgM nephropathy
(Kamatsoda et al., 1996). The seroprevalence of HCV is
thought to be greater in individuals with chronic glomerul-
opathy compared with those suffering from other renal
disease (Daghestani and Pomeroy, 1999).
While some studies conducted on a limited number of
patients have failed to detect HCV protein in tissues from
HCV-positive patients (Johnson et al., 1994; Stokes et al.,
1997), others have reported successful detection of HCV
proteins in renal tissues of HCV-infected patients (Okada
et al., 1996; Sansonno et al., 1995, 1996).
A paucity of studies detected at a systematic analysis of
HCV both liver and renal biopsy specimens and from
patients with HCV-associated glomerulonephritis utilizing
light and EM techniques prompted us to carry out such a
study. Results of such a study constitute the basis of this
report.Materials and methods
Patient population
The study comprised the evaluation of a total of 233
patients that were screened at the Urology and Nephrology
clinic located in Mansoura, Egypt. The study protocol was
approved by our local human investigation committee
(HIC) forum at the initiation of the study and appropriate
uniform consent obtained from each patient in their native
language.
All patients presented to our outpatient clinic complain-
ing from symptoms suggestive of renal disease during a 2-
year period. Each patient was screened for serum HCV
antibodies using a 3rd generation ELISA technique (Abbott
Diagnostics, Maidenhead, UK). Seropositive cases were
confirmed to have HCV-RNA by polymerase chain
reaction (Amplicor PCR diagnostics, Roche Diagnostic
system, Lewes, UK).
Fifty of the 233 patients – among 90– who tested positive
for HCV RNA – were selected for the present study. They
were adults and all have manifestations of glomerulopathy
(proteinuria, hematuria). None of these patients was either
HIV1 or 2 positive (Murex immunoassay) or HBV-positive.
Secondary causes of glomerulonephritis were excluded by
testing for fasting and 2 hour post-prandial levels of blood
glucose, autoimmune antibodies (Serum autoantibodies) and
Schistosmal circulating cathodic antigen (double antibody
sandwich ELISA technique). All included patients were
subjected to thorough laboratory investigations including
urinalysis, serum creatinine, electrolytes, liver function test,
and prothrombin time estimation.Histological work-up
Light microscopy
While renal biopsies were carried out for all selected
patients, liver biopsies were performed in only 10/50 (20%)
with high liver enzymes. Biopsy tissue specimens were
fixed in formalin and embedded in paraffin. 4 um sections
were cut and stained with hematoxylin and eosin.
Polymerase chain reaction for formalin-fixed paraffin
embedded renal and liver sections
RNA Isolation. 1 ml Xyelene was added to 30 um of the
paraffin sections in autoclaved Eppendorf tubes and the
tubes incubated for 10 min at room temperature. The fluid
was removed following centrifugation for 2 min and then
1 ml of 100% ethanol added to the tubes which were
incubated for 10 min at room temperature. This step was
followed by two alternative RNA extraction procedures.
The first one termed the Guanidinium Isothiocyanate
method (200 UL volume of Guanidinium Isothiocyanate
was added, 4 different choices were tried 15 min
incubation at room temperature, 15 min incubation at
4 C, Overnight incubation at room temperature and
overnight incubation at 4 C). The second extraction
procedure termed the Proteinase K digestion method: using
Proteinase K buffer preparation(100 mM NaCl +10 mM
Tris pH 7.4 + 25 mM EDTA pH 8(Autoclaved for 24 h) +
5% Sodium dodecyl sulphate. 10 ml of the buffer was
prepared by adding 1 ml from each to 6 ml PCR water. The
digestion was performed in a 200-UL volume utilizing
different concentrations (0.5 Ag/ml–5 mg/ml).
Complementary DNA (cDNA) synthesis. The protocol
utilized the first strand cDNA kit-Pharmacia 27-9261-01. 4
UL RNAwas first heated to 65 C (on heat block) for 10 min
then chilled on ice. A master Mix was prepared which
constitutes of (2.5 Al bulk 1st strand reaction mix + 0.5 Al
DTT + 0.5 Al primer (Pd (N) 6)+ 4 Al of the heat denatured
RNA is added to 3.5 aliquots, mixed by pipetting, incubated
at 37 C for 1 h.
First round PCR. Master Mix was Prepared by adding
(2.5 UL 10  buffer (Boehringer Mannheim 306527) + 0.25
UL dNTPs 10 AM (Boehringer Mannheim 158295) + O.3
UL Tag DNA Polymerase (Boehringer Mannheim
306528) + 1 UL outer primer (sense) + 1 UL outer primer
(antisense) + 20.1 UL PCR water + Outer primer sequences:
chosen from the highly conserved untranslated 5’ region
(Life Technologies Ltd., UK)-Sense (AGC GTC TAG CCA
TGG CGT), Antisense (GCA CGG CTC ACG AGA CCT),
(Outer product runs from 74 to 338). 1 UL of the cDNAwas
added to 24 UL of the master mix, overlaid with mineral Oil
to prevent evaporation. A thermal cycler was used (PTC-
100 programmable thermal controller) set for 94 C for 45 s
(Denaturing), 50 C for 45 s (Annealing) and 72 C for 120 s
(Extension) for 35 cycles.
Table 1
Results of renal biopsy in 233 Egyptian patients with glomerulopathy
Histological classes Frequency Percent
Membranoproliferative GN 91 39
Focal segmental glomerulosclerosis 71 30.4
Diffuse Mesangioproliferative GN 30 12.8
Membranous nephropathy 10 4.29
Focal mesangial proliferative GN 8 3.4
Crescentic glomerulonephritis 5 2.14
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primer-GTG GTC TGC GGA ACC GG (sense), 1 UL inner
primer-GGG CAC TCG CAA GCA CCC (antisense) (Life
Technologies Ltd., UK)(Inner product runs from 143 to 316),
1 UL of the first round product was added to 24 UL of the
master mix, overlaid withmineral oil. The same thermal cycle
was used (PTC-100 programmable thermal controller MJ-
Research INC) set up 94 C for 45 s, 50 C for 45 s and 72 C for
120 s for 35 cycles. The PCR product was visualized under
ultraviolet illumination, captured by Polaroid Ca-5 camera on
a 2% agarose gel.
Polymerase chain reaction for renal frozen sections
Frozen renal tissue was first homogenized using a
glass homogenizer and plunger in 500 UL of solution
D. The rest of the steps for RNA extraction were the
same as utilized for formalin fixed paraffin embedded
sections.
Electron microscopy
Freshly cut biopsies were transferred immediately to a
dish of modified Millonig’s phosphate buffer (18.76 g of
sodium dihydrogen phosphate (2H2O) + 4.28g of Sodium
Hydroxide + 1 l of distilled water + 3% phosphate-
buffered glutaraldehyde + 12 ml of concentrated (25%)
glutaraldehyde).
Half micron sections were cut and mounted on glass
slides. The sections were heated at 150 8C for at least 5 min,
stained with 1% aqueous toluidine blue in 1% sodium
tetraborate for 15 s on same hot plate at 1508, allowed to
cool and then excess stain was rinsed in xylene and
coverslipped. The sections were examined under light
microscope for assessable glomeruli. Additional sections
were cut using a diamond knife utilizing Leica Ultracut E
Ultramicrotome at interferance color gold (Approximately
95 nm thick). The section was picked up on a 200-mesh
high transmission hexagonal copper grid left for half an hour
at least to dry into grid at 37 8C, or overnight at room
temperature. The sections were then stained and examined
using a Philips 400 T TEM. Relevant areas were photo-
graphed, film developed and printed.
Statistical analysis
Results are presented as median and confidence intervals.
The Fisher exact probability test and Mann–Whitney (Non
parametric rank sum tests) were applied as appropriate. A
P value of V 0.05 was considered significant.
Minimal change Nephropathy 4 1.71
Amyloidosis 4 1.71
IgA nephropathy 3 1.71
Normal by light microscopy 3 1.2
Tubulo interstitial fibrosis 2 0.8
Diabetic glomerulosclerosis 1 0.4
End stage renal disease 1 0.4
Total 233 100
T GN = glomerulonephritis.Results
Prevalence of HCV
Ninety of 233 patients (38%) were positive for HCVAb
by 3rd generation ELISA. Fifty of these patients fulfilledour inclusion criteria were subjected to more detailed
clinical, biochemical and histological analysis.
Histological study of renal biopsies
Histological evaluation of renal biopsies from the 233
patients revealed MPGN and focal segmental glomerulo-
sclerosis as the most common lesions observed accounting
for 39% and 30.4%, respectively, among 233 patients
presented with glomerulopathy (Table 1).
Clinical characteristics of HCV-positive patients
Male preponderance was observed among HCV-pos-
itive patients (70%). A past history of hospital admission
(27 patients); blood transfusion (21 patients) and oper-
ative procedures (25 patients) were considered as risk
factors for HCV acquisition. Twenty-three (56%) gave
history of previous Schistosomal infection and its treat-
ment, none tested positive for Schistosomal circulating
cathodic antigen.
Biochemical characteristics
Among the 50 HCV-positive patients 27 were cryoglo-
bulinemic, 18 patients were positive for rheumatoid factor,
mean serum creatinine was 1.2 mg/dl, 24 h protein excretion
was 3.7 g, and their levels of C 3 were normal but low for
C4 (Table 2).
There was statistically no significant difference regard-
ing demographic and clinical characteristics between
cryoglobulinemic and non-cryoglobulinemic patients. The
only difference between both groups is that the former
received more blood transfusion. In addition, the cryoglo-
bulinemic patients had statistically higher levels of serum
creatinine and lower but not statistically significant levels
of C3 (Table 3).
Table 2
Results of laboratory tests on blood samples from 50 HCV-positive patients
presented with glomerular disease (median and confidence interval)
Parameters
Serum creatinine (mg/dl) 1.2 (1.15–1.47)
Proteinuria 24 h (g) 3.7 (3.66–6.00)
Serum cholesterol (mg/dl) 220.00 (226.08–310.04)
Hemoglobin (gm/dl) 12 (10.83–12.73)
Platelet count mm3 217 (195.76–280.41)
White cell count (mm3) 6.75 (6.43–8.56)
Serum bilirubin (mg/dl) 0.50 (0.45–0.94)
Total protein (gm/dl) 6.05 (5.61–6.27)
Table 4
Histological diagnosis of HCV-positive patients
Histological diagnosis (n = 50)
Membranoproliferative glomerulonephritis type 1 27
Monocyte infiltration 17
Intraluminal hyaline thrombi 6
Accentuated lobular architecture 5
Focal segmental glomerulosclerosis 12
Membranous nephropathy 2
Mesangioproliferative glomerulonephritis 9
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of 27 patients revealed mixed cryoglobulinemia (Both IgM
and IgG) in 25 of these cases.
Histological characterization
Light microscopy
Results of light microscopy studies showed that 27/50
(54%) of the HCV -positive patients showed evidence of
MPGN type 1. Out of these 27 patients 16 patients were
cryoglobulinemic and 11 patients were non cryoglobuline-
mic. 24% had evidence of FSGS, 4% were MN and 18%
showed evidence of Mesangial proliferative glomerulo-
nephritis (Table 4). Of the 10 patients who had high liver
enzyme values, each showed evidence of mild hepatitis
with Knoddel scoring ranging from 2 to 9 in their liver
biopsies (Table 5).
Electron microscopy
Immune complexes (IC) were detected in biopsy sections
from 11 patients out of 20 samples examined. The IC appears
to be located in the paramesangial and subendothelial spaces
(Fig. 1).
With higher magnification (Fig. 2) viral-like particles
were localized within these immune complexes in 5
sections. These findings were specific since similar analysisTable 3
Demographic and clinical characteristics for cryoglobulinemic and non-






Age 40 (35.97–43.95) 45 (38.69–46.60 ) 0.283
Gender Male, 17 18 0.239
Anasarca 16 14 0.908
Jaundice 3 3 0.834





Serum creatinine 1.43 F .49 1.21F 0.16
Serum
complement C3
90.40 F 46.18 116.24 F 51.88 0.07
Serum
complement C4
30.95 F 11.6 33.1 F 11.95 0.89of biopsies from HCV-negative patients proved negative
both for immune complexes and viral-like particles.
Polymerase chain reaction
Forty-two frozen renal biopsy samples were tested for
HCV RNA by a nested PCR technique as described in the
methods section. Of these 42 specimens 9 samples were
positive, 4 from patients with cryoglobulinemic and 5 who
were non-cryoglobulinemic (Figs. 3 and 4). HCV RNAwas
detected in liver biopsies from six of the 10 patients. HCV
was also detected in 17 samples out of the 25 cryoprecipitate
from HCV-positive cryoglobulinemic patients.Discussion
Hepatitis C is a global health problem affecting a
significant portion of the world’s population. The World
Health Organization estimated that in 1999, 170 million
hepatitis C virus (HCV) carriers were present worldwide,
with 3 to 4 million new cases per year. Based on data in
blood donors from varying regions of the world, the
infectivity rates range from 0.3% to 14.5%. The prevalence
of HCV antibodies is relatively low in the United States,
northern Europe, and Australia, ranging from 0.3% to 1.2%
of the population (Robert and Paul, 2003).Table 5
Clinical and histological criteria of patients with high liver enzymes
Parameter Range (minimum–maximum)
Serum creatinine 1.5 (0.7–2.2)
24 h urinary protein 5.8 (0.5–6.3)
Cholesterol 332 (108–440)
Total protein 2.7 (5.2–7.9)
Serum albumin 2.4 (1.3–3.7)
ALT 63 (8–71)
AST 46 (12–56)
Serum complement 3 171 (60–231)
Serum complement 4 21.6 (10.2–31.8)
Knoddel scoring for liver biopsy
Portal fibrosis 3 (0–3)
Portal inflammation 2 (1–3)
Piece meal necrosis 3 (0–3)
Spotty necrosis 2 (1–3)
Total scoring 7 (2–9)
Fig. 1. Electron microscopy for HCV-positive patient with viral like
particles in the electron dense deposits (56 nm) 248418.
Fig. 2. Electron microscopy for HCV-positive patient with viral like
particles in the electron dense deposits (56 nm) 248418.
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proportion with up to 21.9% of the population affected
(Darwish et al., 1993).
In addition to liver disease, HCV infection has been
associated with a wide variety of extrahepatic manifesta-
tions including mixed cryoglobulinemia and renal involve-
ment (Wilson, 1997). The most common form of renal
disease is cryoglobulinemic membranoproliferative Glomer-
ulonephritis, MPGN type 1 (D’Amico et al., 1989). This
finding is consistent with a previous report that postulated
that HCV is a significant cause of MPGN, especially in
countries where HCV is highly prevalent (Bandi, 2003).
Results of our study also confirmed this observation
since MPGN represents 39% of the population studied
herein. It is important to note that the prevalence of HCV
antibodies among patients with glomerulopathy (38%) was
higher than among healthy blood donors (16%) which could
be attributed to the association of HCV with renal disease.
Despite of the high prevalence of HCV among patients
with chronic glomerulopathy, the histological characteristics
and the prevalence of HCV-associated glomerulopathy
remains to be determined.
The typical renal histological evaluation by light micro-
scopy showed changes of MPGN and evidence of immune
complex deposits in the glomeruli. Glomerular capillaries
may have marked inflammatory cellular infiltrates with both
mononuclear cells and polymorphonuclear leucocytes with
accentuation of the glomerular lobulation and the tuft
architecture and may have a combination of increased
mesangial cellularity and matrix, capillary endothelial
swelling, splitting of capillary basement membrane and
intracapillary global accumulation of esinophilic material
representing precipitated immune complexes or cryoglobu-
lins (Johnson et al., 1993).
In our study marked inflammatory cellular infiltrates –
mainly monocyte – was evident in biopsies from 63% of the
patients, intra-capillary hyaline thrombosis was found inbiopsies from 23% of patients and accentuation of glomerular
lobulation in biopsies from 63% of patients.
Symptoms suggestive of cryoglobulinemia, such as
purpura, arthritis or neuropathy, were present in only one
half of HCV-infected patients with MPGN. In addition, only
20% of the patients had physical signs of liver disease,
although the majority (60–70%) has mildly elevated serum
transaminases.
Results of our study revealed that while 26% of the
HCV-positive patients with cryoglobulinemia had elevated
transaminase levels, only 10% had hepatomegaly, 6% had
acral necrolytic erythema. These values are consistent with
those reported by Wilson (1997). However, these values are
not in agreement with Johnson et al. (1993, 1994) where
two thirds of patients had high liver enzymes. The lack of
extra-renal manifestations – particularly hepatic – in the
majority of our patients may be explained by the fact that
even those with high transaminase levels were biopsy
proven to have mild hepatitis with Knoddel scoring.
It has been previously reported that the most reliable
method for the diagnosis of HCV infection is the detection
of viral RNA sequences by RT-PCR in serum and tissues
(Akyol et al., 1992). While the non replicating form of HCV
was successfully detected in paraffin-embedded renal
biopsies, the viral replication could not be detected (Agnello
et al., 1996) in these studies.
We tried many methods for RNA extraction from both
formalin fixed and frozen liver and kidney tissues and also
from the cryoprecipitates isolated from cryoglobulinemic
patients. However we failed to extract HCV RNA from
formalin-fixed, paraffin-embedded renal sections. These find-
ings could be explained by the fact that HCV being a RNA
virus is more labile than DNA viruses and susceptible to
damage by the process of fixation and prolonged paraffin
embedding (Shieh et al., 1991). This explanation is confirmed
by our success in the isolation of HCV RNA from 22% of the
frozen renal sections studied, four of them were from
cryoglobulinemic MPGN patients, 2 MN, 2 FSGS and one
mesangioproliferative glomerulonephritis. RNA was also
Fig. 3. PCR for HCV RNA in frozen renal tissues for cryoglobulinemic patients. *Positive samples are highlighted in red. (For interpretation of the references
to colour in this figure legend, the reader is referred to the web version of this article.)
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success of RNA extraction from liver sections but not in renal
sections might be explained in part by the fact that the liver is
the major site for HCV replication and it may contain
relatively higher viral load than renal tissue.
Detection of HCV by EM has been reported in a few
studies and case reports which described the detection of
aggregated or single viral like particles in the cytoplasm of
hepatocytes in sections from HCV-infected patients (Bos-Fig. 4. PCR for HCV RNA in frozen renal tissues for non cryoglobulinemic pa
references to colour in this figure legend, the reader is referred to the web versioman et al., 1998). To our knowledge, only one case in renal
tissue was reported (Horikoshi et al., 1993). On the contrary,
herein virus-like particles, mostly HCV-related, of about
30–45 nm in diameter, located in Electron-dense deposits in
the paramesangial areas in 5 out of 20 sections examined in
cryoglobulinemic MPGN patients.
In conclusion, the prevalence of HCV infection is higher
among Egyptian patients with chronic glomerulonephritis
when compared to the general population. The hightients. *Positive samples are highlighted in red. (For interpretation of the
n of this article.)
A. Sabry et al. / Virology 334 (2005) 10–1616prevalence of MPGN in areas endemic for HCV could be
attributed to such infection. MPGN-associated with HCV
has peculiar histological features.
To our knowledge, results of the studies reported herein
are the first that documents the detection of HCV particles in
renal tissues in such number of patients. Our recommenda-
tion is to screen all patients with MPGN in endemic areas
for HCV infection. Finally, combination of EM and PCR
could help to establish diagnosis.References
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